What are the first two steps for treating exercise-induced bronchospasm?

The first steps in treating exercise-induced bronchospasm (EIB) focus on bronchodilation and bronchodilator therapy, making the choice of inhaled beta-2 agonist appropriate. These medications work by relaxing the muscles of the airways, leading to widening of the air passages and making it easier for individuals to breathe. They are particularly effective when administered shortly before exercise to prevent the onset of symptoms associated with EIB.

Inhaled beta-2 agonists are rapid-onset medications commonly used for quick relief during episodes of bronchospasm. The combined option of inhaled beta-2 agonist with cromolyn sulfate further supports prevention, as cromolyn acts as a mast cell stabilizer and is helpful in reducing inflammatory responses related to exercise. This dual approach enhances the prevention of bronchospasm during exercise, underscoring the efficacy of this choice in addressing EIB.

Other treatment modalities such as inhaled corticosteroids and long-acting beta agonists are typically considered for long-term management of asthma or chronic bronchospasm rather than immediate intervention for exercise-induced symptoms. Additionally, using oral steroids or anticholinergics may not have the same effectiveness in acutely managing the symptoms associated with EIB.